Pfizer Financial News

10.08 / 15:37

UPS Target Pfizer show track country A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence

Omicron variant gains momentum. The continued evolution of the virus is a reminder that Covid-19 remains a nuisance for many and a serious risk for some even though the disease is far less disruptive than it once was. A rising tide of virus concentrations in wastewater and infections in hospitals show Covid-19 remains unpredictable.

07.08 / 18:07

UPS Provident Manufacturing CEO Pfizer show Drug Shortages Are a Boon to One Industry: Compounding Pharmacies

Pfizer manufacturing plant that produced 8% of sterile injectable medicines used by U.S. hospitals. Lobbyists for compounders say they could do more to help with shortages if they had more regulatory flexibility.

05.08 / 13:21

Citi Digital Man Aviat Pfizer CCL dividend Power week Dividend Stocks: ICICI Bank, Power Grid, Bharti Airtel, among others to trade ex-dividend next week; check details

₹10 to Re 1 on August 11, 2023. Here we list out details in regard to the some of the dividend stocks: RITES Ltd: The company has declared an interim dividend of ₹3.7500. It will trade ex-dividend on August 7, 2023.

04.08 / 20:27

COST Provident Fighting Pfizer Immunic cover rsv approved Babies should get recently approved drug for RSV, CDC says

U.S. health officials are recommending that babies get a recently approved drug to protect them against a respiratory virus

03.08 / 18:57

Pfizer Rocky Pfizer taking additional steps to manage inventory at Rocky Mount Plant

(Reuters) — Pfizer Inc (NYSE:PFE) on Thursday said the drugmaker will make some products available only through its emergency ordering process until further notice, as part of its additional steps to manage inventory at its Rocky Mount facility.

03.08 / 18:21

UPS Moderna Pfizer Patrick country Moderna sees up to $4 billion in 2023 sales from private market for COVID shots

By Leroy Leo and Patrick Wingrove

03.08 / 12:31

UPS MET Racing Moderna Pfizer Moderna revenue beats estimates despite COVID vaccine sales slump

Investing.com — Moderna (NASDAQ:MRNA) has reported better-than-expected revenue in the second quarter despite falling steeply due to weaker post-pandemic demand for its COVID-19 vaccine.

02.08 / 13:45

COST UPS CEO Pfizer COVID-19 Vaccine Pfizer 2Q numbers tumble and COVID-19 vaccine, treatment sales dry up

Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023

02.08 / 07:59

Digital Pfizer performer Yes Bank, United Breweries, 7 others gain momentum by crossing 200-day SMA

200-day Simple Moving Average (SMA) on 1st August 2023. Companies like Yes Bank, Navin Fluorine International, United Breweries, Brightcom Group, Vedant Fashions, and Nocil showcasing strong performance in their respective sectors. Let's explore the performance of these stocks.

01.08 / 23:03

COST UPS CEO Pfizer COVID-19 Vaccine Pfizer 2Q numbers tumble and COVID-19 vaccine, treatment sales dry up

Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023

01.08 / 20:47

NASDAQ HSBC DAX Pfizer reports 500 Global markets update: S&P 500, Nasdaq edge lower on mixed set of earnings reports

Pfizer edged 1.2% lower after its quarterly revenue fell short of analysts’ expectations. European stocks declined on Tuesday, on shrinking factory activity in the euro zone. The pan-European benchmark STOXX 600 fell 0.9%.

01.08 / 15:35

Manufacturing Assurant Pfizer Seagen track Pfizer Q2 Results: Profit tumbles 77% to $2.3 billion; co trims 2023 revenue outlook

Pfizer reported a steep drop in profits Tuesday on much lower Covid-related revenues as it curtailed its full-year sales outlook, in part due to tornado damage to a key manufacturing facility. Profits in the second quarter were $2.3 billion, down 77% as revenues fell 54% to $12.7 billion. Quarterly revenues for Pfizer's Covid-19 vaccine and Paxlovid therapeutic were $1.6 billion, far below the $16.9 billion in the year-ago period.

01.08 / 14:03

NASDAQ DOW Merck Pfizer stage U.S. stocks were wobbling as investors take in megacap earnings

Investing.com — U.S. stocks were wobbling as investors digested a slew of megacap earnings reports and awaited economic data that could set the stage for the Federal Reserve’s next meeting.

01.08 / 13:25

Manufacturing Caterpillar Merck Pfizer show open Wall St set to open lower ahead of manufacturing, jobs data

By Johann M Cherian and Bansari Mayur Kamdar

01.08 / 13:05

Amazon Platform Caterpillar Merck Pfizer JetBlue fall Caterpillar, Merck rise premarket; Pfizer, JetBlue and ZoomInfo fall

Investing.com — U.S. futures edged lower Tuesday, with investors digesting more corporate earnings as well as key job openings data.

01.08 / 13:05

COST Lowe's Target Pfizer Pfizer mulls cost cuts on volatile COVID products demand

(Reuters) — Pfizer (NYSE:PFE) will launch a cost-cutting program if demand for its COVID-19 products keeps underperforming expectations this fall, the U.S. drugmaker said on Tuesday, after quarterly sales for the vaccine and pill fell short of Wall Street targets.

01.08 / 12:27

Target CEO Gap Caterpillar Merck Pfizer Incyte Stocks making the biggest moves premarket: Uber, Gap, Caterpillar & more

Check out the companies making headlines before the bell on Tuesday.

01.08 / 09:53

UPS Provident Pfizer Browser Verizon performer Value investing - 3 US share ideas for value investors

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

01.08 / 04:15

UPS Citi FIVE Pfizer track symptoms New study to focus on treatment for long Covid that causes symptoms like brain fog, sleep disorder

long COVID, an anxiously awaited step in U.S. efforts against the mysterious condition that afflicts millions. Monday's announcement from the NIH's USD 1.15 billion RECOVER project comes amid frustration from patients who've struggled for months or even years with sometimes-disabling health problems — with no proven treatments and only a smattering of rigorous studies to test potential ones.

31.07 / 16:41

Pfizer US NIH launches long-COVID trials of Pfizer's Paxlovid, other therapies

(Reuters) — The U.S. National Institutes of Health (NIH) said on Monday that it had launched mid-stage clinical trials to test at least four treatments, including Pfizer (NYSE:PFE)'s Paxlovid, in patients with symptoms of long COVID.

30.07 / 21:33

UPS ETF DOW Apple Pfizer week 1 Stock to Buy, 1 Stock to Sell This Week: Apple, Pfizer

Stocks on Wall Street rallied on Friday to wrap up an action-packed week, as investors cheered data showing cooling inflation and stronger-than-expected earnings that supported the case that the U.S. economy can manage a soft-landing.

frequently asked questions about Pfizer

What is Pfizer and why is it relevant?

Pfizer is a high-demand area that is in the spotlight. On our site, we regularly publish updates related to this subject.

Where can I find the latest updates on Pfizer?

All latest articles about Pfizer can be found in the highlighted block. We publish information regularly.

How can I verify the accuracy of information on Pfizer?

We consult with professionals to ensure that the information about Pfizer is well-supported and helpful for our readers.